StoneX Group’s Fortress Biotech FBIO Stock Holding History

StoneX Group’s Portfolio FBIO Stock Details FBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$39.2K	Buy	+16,055	New	+$46.1K	﹤0.01%	1648

Other funds holding FBIO

Mackenzie Financial Toronto Ontario, Ontario, Canada $91.6B AUM 30% 1-Year Est. Return

Shikiar Asset Management New York $398M AUM 33.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

HB Wealth Management Atlanta, Georgia $19.5B AUM 16.96% 1-Year Est. Return

Kestra Advisory Services Austin, Texas $35.1B AUM 20.13% 1-Year Est. Return

180 Wealth Advisors Federal Way, Washington $1.04B AUM 41.44% 1-Year Est. Return

LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return

Choreo LLC Rockford, Illinois $9.7B AUM 18.43% 1-Year Est. Return

Provenance Wealth Advisors Fort Lauderdale, Florida $1.69B AUM 11.53% 1-Year Est. Return

Creative Planning Overland Park, Kansas $179B AUM 16.96% 1-Year Est. Return

StoneX Group's FBIO Position: Q3 2026 in Review

StoneX Group opened a new position in Fortress Biotech (FBIO) in Q3 2026: 16,055 shares worth $39.2K. The stake represents ﹤0.01% of the portfolio and ranks #1648 among its holdings.

18 funds tracked by Wall St. Rank hold FBIO as of Q3 2026.

StoneX Group held 16,055 shares of Fortress Biotech worth $39.2K as of Q3 2026.
Fortress Biotech was a new StoneX Group position in Q3 2026.
Fortress Biotech made up ﹤0.01% of StoneX Group's portfolio in Q3 2026, its #1648 holding.
18 funds tracked by Wall St. Rank held Fortress Biotech as of Q3 2026.

Based on StoneX Group's 13F filing for Q3 2026, filed 3 Nov 2026.